Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anita M, Kelsey"'
Autor:
Saman Rostambeigi, Homa Mazaherinia, Negin Mahmoudi Hamidabad, Anita M. Kelsey, Azin Alizadehasl, Seyed Taha Hosseini Harandi, Khashayar Farnoud, Parsa Panahi, Ata Firouzi, Anita Sadeghpour
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Percutaneous balloon mitral valvuloplasty (PBMV) is the ACC/AHA class I recommendation for treating symptomatic rheumatic mitral stenosis with suitable valve morphology, less than moderate MR and absence of left atrium clot. The m
Externí odkaz:
https://doaj.org/article/8bfd44f99faf4150b325a5188e422730
Autor:
Caitlin S. Drescher, Michelle D. Kelsey, George S. Yankey, Albert Y. Sun, Andrew Wang, Anita Sadeghpour, Donald D. Glower, Sreekanth Vemulapalli, Anita M. Kelsey
Publikováno v:
Circulation. Cardiovascular imaging. 15(9)
Mitral annular disjunction is increasingly recognized as an important anatomic feature of mitral valve disease. The presence of mitral annular disjunction, defined as separation between the left atrial wall at the point of mitral valve insertion and
Autor:
Homa Mazaherinia, Negin Mahmoudi Hamidabad, Saman Rostambeigi, Anita M. Kelsey, Azin Alizadehasl, Anita Sadeghpour, Seyed Taha Hosseini Harandi, Khashayar Farnoud, Parsa Panahi
Background Percutaneous mitral valvuloplasty (PMV) is a safe and widely used treatment in patients with symptomatic rheumatic mitral stenosis. This study aimed to evaluate short-term and mid-term outcomes of PMV in patients with severe mitral stenosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d09bf215e749351042a31a51987c64c8
https://doi.org/10.21203/rs.3.rs-2053213/v1
https://doi.org/10.21203/rs.3.rs-2053213/v1
Autor:
Anita M. Kelsey, Michelle D Kelsey, Manesh R. Patel, Stuart D. Russell, Robert J. Mentz, Vishal N. Rao, Marat Fudim
Publikováno v:
Clinical Cardiology
Background Cardiovascular disease (CVD) hospitalizations declined worldwide during the COVID-19 pandemic. It is unclear how shelter-in-place orders affected acute CVD hospitalizations, illness severity, and outcomes. Hypothesis COVID-19 pandemic was
Autor:
Michael A. Blazing, L. Kristin Newby, Jonathan P. Piccini, Anita M. Kelsey, Michael Rehorn, Manesh R. Patel, Rahul S. Loungani, Igor Klem, Sreekanth Vemulapalli, W. Schuyler Jones, Robert J. Mentz, Jason N. Katz
Publikováno v:
American Heart Journal
The infection caused by severe acute respiratory syndrome coronavirus-2, or COVID-19, can result in myocardial injury, heart failure, and arrhythmias. In addition to the viral infection itself, investigational therapies for the infection can interact
Autor:
Anthony Peters, Robert M. Clare, Karen E. Chiswell, Josephine Harrington, Anita M. Kelsey, Adrian F. Hernandez, G. Michael Felker, Robert John Mentz, Adam DeVore
Publikováno v:
Journal of the American College of Cardiology. 81:617
Autor:
Anthony P. Carnicelli, Robert M. Clare, Paul Hofmann, Karen Chiswell, Adam D. DeVore, Sreekanth Vemulapalli, G. Michael Felker, Anita M. Kelsey, Tracy A. DeWald, Phil Sarocco, Robert J. Mentz
Publikováno v:
American heart journal. 245
Recent data suggest that patients with heart failure with reduced ejection fraction (HFrEF) and worsening heart failure (WHF) have potential for greater benefit from newer HF therapies. We investigated characteristics and outcomes of patients with HF
This textbook provides an invaluable resource for multidisciplinary medical professionals performing structural heart interventions. Chapters contain clear, easy-to-follow guidance on the use of multi-modality imaging and clinical decision-making. De
Autor:
Marat Fudim, Karol Harshaw-Ellis, Debra J. Barksdale, Dennis M. Abraham, Anita M. Kelsey, Tracy Truong, William E. Kraus, Cynthia L. Green, Kishan S. Parikh, Robert J. Mentz, Carolyn L. Lekavich, Margaret Bowers
Publikováno v:
Journal of cardiac failure. 27(9)
Heart failure with preserved ejection fraction (HFpEF) continues to increase in prevalence with a 50% mortality rate within 3 years of diagnosis, but lacking effective evidence-based therapies. Specific echocardiographic markers are not typically use
Autor:
Matthew Nudy, Anita M. Kelsey, Jean Wactawski-Wende, Xuezhi Jiang, JoAnn E. Manson, Erin S. LeBlanc, John A Robbins, Aladdin H. Shadyab, Marcia L. Stefanick, Jonathan D. Buerger, Andrew Foy, Aaron K. Aragaki, Robert A. Wild, Peter F. Schnatz
Publikováno v:
Web of Science
This study evaluated whether vasomotor symptom (VMS) severity and number of moderate/severe menopausal symptoms (nMS) were associated with health outcomes, and whether calcium and vitamin D (CaD) modified the risks.The Women's Health Initiative CaD s